Annual Operating Profit
-$134.82 M
-$41.36 M-44.26%
December 31, 2024
Summary
- As of March 13, 2025, TCRX annual operating income is -$134.82 million, with the most recent change of -$41.36 million (-44.26%) on December 31, 2024.
- During the last 3 years, TCRX annual operating profit has fallen by -$86.18 million (-177.18%).
- TCRX annual operating profit is now -848.78% below its all-time high of -$14.21 million, reached on December 31, 2019.
Performance
TCRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$36.71 M
-$4.09 M-12.54%
December 31, 2024
Summary
- As of March 13, 2025, TCRX quarterly operating income is -$36.71 million, with the most recent change of -$4.09 million (-12.54%) on December 31, 2024.
- Over the past year, TCRX quarterly operating profit has stayed the same.
- TCRX quarterly operating profit is now -553.70% below its all-time high of -$5.62 million, reached on June 30, 2020.
Performance
TCRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$134.82 M
-$15.36 M-12.85%
December 31, 2024
Summary
- As of March 13, 2025, TCRX TTM operating income is -$134.82 million, with the most recent change of -$15.36 million (-12.85%) on December 31, 2024.
- Over the past year, TCRX TTM operating profit has stayed the same.
- TCRX TTM operating profit is now -2292.14% below its all-time high of -$5.64 million, reached on March 31, 2020.
Performance
TCRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
TCRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.3% | 0.0% | 0.0% |
| 3 y3 years | -177.2% | -48.3% | -48.6% |
| 5 y5 years | -848.8% | -48.3% | -48.6% |
TCRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -177.2% | at low | -158.5% | at low | -177.2% | at low |
| 5 y | 5-year | -848.8% | at low | -553.7% | at low | -2292.1% | at low |
| alltime | all time | -848.8% | at low | -553.7% | at low | -2292.1% | at low |
TScan Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$134.82 M(+44.3%) | -$36.71 M(+12.5%) | -$134.82 M(+12.9%) |
| Sep 2024 | - | -$32.62 M(-4.4%) | -$119.47 M(+7.1%) |
| Jun 2024 | - | -$34.11 M(+8.7%) | -$111.59 M(+9.3%) |
| Mar 2024 | - | -$31.37 M(+46.9%) | -$102.09 M(+9.2%) |
| Dec 2023 | -$93.46 M(+40.3%) | -$21.36 M(-13.7%) | -$93.46 M(+3.0%) |
| Sep 2023 | - | -$24.75 M(+0.6%) | -$90.75 M(+9.9%) |
| Jun 2023 | - | -$24.61 M(+8.2%) | -$82.58 M(+12.8%) |
| Mar 2023 | - | -$22.74 M(+22.0%) | -$73.22 M(+9.9%) |
| Dec 2022 | -$66.64 M | -$18.65 M(+12.5%) | -$66.64 M(+7.2%) |
| Sep 2022 | - | -$16.58 M(+8.7%) | -$62.19 M(+1.2%) |
| Jun 2022 | - | -$15.25 M(-5.7%) | -$61.45 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.16 M(+13.8%) | -$56.89 M(+17.0%) |
| Dec 2021 | -$48.64 M(+85.4%) | -$14.20 M(-10.4%) | -$48.64 M(+15.1%) |
| Sep 2021 | - | -$15.84 M(+48.3%) | -$42.25 M(+25.8%) |
| Jun 2021 | - | -$10.68 M(+34.9%) | -$33.58 M(+17.8%) |
| Mar 2021 | - | -$7.92 M(+1.4%) | -$28.52 M(+8.7%) |
| Dec 2020 | -$26.23 M(+84.6%) | - | - |
| Dec 2020 | - | -$7.81 M(+8.9%) | -$26.23 M(+42.4%) |
| Sep 2020 | - | -$7.17 M(+27.7%) | -$18.42 M(+63.7%) |
| Jun 2020 | - | -$5.62 M(-0.4%) | -$11.25 M(+99.6%) |
| Mar 2020 | - | -$5.64 M | -$5.64 M |
| Dec 2019 | -$14.21 M | - | - |
FAQ
- What is TScan Therapeutics annual operating income?
- What is the all time high annual operating profit for TScan Therapeutics?
- What is TScan Therapeutics annual operating profit year-on-year change?
- What is TScan Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for TScan Therapeutics?
- What is TScan Therapeutics quarterly operating profit year-on-year change?
- What is TScan Therapeutics TTM operating income?
- What is the all time high TTM operating profit for TScan Therapeutics?
- What is TScan Therapeutics TTM operating profit year-on-year change?
What is TScan Therapeutics annual operating income?
The current annual operating profit of TCRX is -$134.82 M
What is the all time high annual operating profit for TScan Therapeutics?
TScan Therapeutics all-time high annual operating income is -$14.21 M
What is TScan Therapeutics annual operating profit year-on-year change?
Over the past year, TCRX annual operating income has changed by -$41.36 M (-44.26%)
What is TScan Therapeutics quarterly operating income?
The current quarterly operating profit of TCRX is -$36.71 M
What is the all time high quarterly operating profit for TScan Therapeutics?
TScan Therapeutics all-time high quarterly operating income is -$5.62 M
What is TScan Therapeutics quarterly operating profit year-on-year change?
Over the past year, TCRX quarterly operating income has changed by $0.00 (0.00%)
What is TScan Therapeutics TTM operating income?
The current TTM operating profit of TCRX is -$134.82 M
What is the all time high TTM operating profit for TScan Therapeutics?
TScan Therapeutics all-time high TTM operating income is -$5.64 M
What is TScan Therapeutics TTM operating profit year-on-year change?
Over the past year, TCRX TTM operating income has changed by $0.00 (0.00%)